{
  "actions": [
    {
      "acted_at": "2025-02-07",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2025-02-07",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2025-02-07",
      "action_code": "H11100",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr1143-119",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "Referred To"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM"
    },
    {
      "activity": [
        "Referred To"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    }
  ],
  "congress": "119",
  "cosponsors": [
    {
      "bioguide_id": "G000559",
      "district": "8",
      "name": "Garamendi, John",
      "original_cosponsor": true,
      "sponsored_at": "2025-02-07",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "V000138",
      "district": "7",
      "name": "Vindman, Eugene Simon",
      "original_cosponsor": false,
      "sponsored_at": "2025-11-04",
      "state": "VA",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2025-02-07",
  "number": "1143",
  "official_title": "To amend title XVIII of the Social Security Act to expand coverage of the in-home administration of intravenous immune globulin under the Medicare program.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Medicare IVIG Access Enhancement Act of 2025",
  "sponsor": {
    "bioguide_id": "S001172",
    "district": "3",
    "name": "Smith, Adrian",
    "state": "NE",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2025-02-07",
  "subjects": [
    "Drug therapy",
    "Health",
    "Health care costs and insurance",
    "Health care coverage and access",
    "Medicare",
    "Neurological disorders"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2025-02-07",
    "date": "2025-04-28T15:27:39Z",
    "text": "Medicare IVIG Access Enhancement Act of 2025\n\nThis bill provides for Medicare coverage of in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy (CIDP) or multifocal motor neuropathy. (CIDP is an autoimmune condition that causes symptoms such as muscle weakness and numbness; multifocal motor neuropathy is a variant of CIDP that only causes asymmetric muscle weakness.)"
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Medicare IVIG Access Enhancement Act of 2025",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Medicare IVIG Access Enhancement Act of 2025",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend title XVIII of the Social Security Act to expand coverage of the in-home administration of intravenous immune globulin under the Medicare program.",
      "type": "official"
    }
  ],
  "updated_at": "2025-11-05T09:05:38Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/119/hr/BILLSTATUS-119hr1143.xml"
}